Haematology 2018

11.7 B n=189 Patients (%) GADOLIN: Response to therapy 69.2 63.0 End-of-induction response (IRF) 10.9 62.0 16.7 0 20 40 60 80 100 G-B n=192** Patients (%) 18.5 9.0 9.0 9.5 10.1 58.0 50.8 11.2 12.2 0 20 40 60 80 100 G-B n=188

Best overall response to 12 months (IRF)

CR PR SD PD NE/missing

17.3

76.7

78.7

59.4

11.7

7.6 4.1

5.7 4.7

B n=197**

* Patients ongoing in induction therapy are excluded from analysis. Patients with end of induction response assessment performed >60 days after last induction dose shown as missing. ** Best overall response excludes ongoing patients who have not yet reached the first response assessment. IRF, independent radiology facility